AllianceBernstein’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

AllianceBernstein’s Portfolio BCEL Stock Details BCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,600	Closed	-$40K	–	3421
2022 Q1	$40K	Sell	12,600 -10,400	-45%	-$25.2K	﹤0.01%	3191
2021 Q4	$70K	Sell	23,000 -4,100	-15%	-$19.1K	﹤0.01%	3224
2021 Q3	$169K	Hold	27,100	–	–	﹤0.01%	3118
2021 Q2	$231K	Buy	27,100 +6,200	+30%	+$63.5K	﹤0.01%	3112
2021 Q1	$320K	Sell	20,900 -2,400	-10%	-$39K	﹤0.01%	2873
2020 Q4	$376K	Buy	23,300 +1,500	+7%	+$22.5K	﹤0.01%	2738
2020 Q3	$305K	Sell	21,800 -600	-3%	-$8.95K	﹤0.01%	2803
2020 Q2	$477K	Buy	22,400 +8,300	+59%	+$147K	﹤0.01%	2644
2020 Q1	$233K	Buy	+14,100	New	+$256K	﹤0.01%	2734

Other funds holding BCEL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

AllianceBernstein's BCEL Position: Q2 2022 in Review

AllianceBernstein sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q2 2022, closing a stake of 12,600 shares — an estimated $40K sold.

AllianceBernstein first reported a position in BCEL in Q1 2020 and held it in 9 quarters. The position peaked at $477K in Q2 2020. 80 funds tracked by Wall St. Rank hold BCEL as of Q2 2022.

AllianceBernstein reported no remaining Atreca, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
AllianceBernstein sold 12,600 Atreca, Inc. Class A Common Stock shares in Q2 2022, an estimated $40K.
AllianceBernstein first reported a position in Atreca, Inc. Class A Common Stock in Q1 2020 and held it in 9 quarters.
AllianceBernstein's Atreca, Inc. Class A Common Stock position peaked at $477K in Q2 2020.
80 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.